Skip to main content

Abilify Gambling Cases Finalized For Fast-track Trial

Abilify Gambling Cases Finalized For Fast-track Trial

Abilify Gambling Cases Finalized For Fast-track Trial

Introduction

In an order issued last week, the Court announced the discovery schedule for six Abilify gambling cases that were selected for a fast-tracked discovery and trial. 

As per the order, case-specific discovery must be completed within January 2019 and March 15, 2019. Expert depositions must be finished at most by April 29, and the court would announce the trial date for Summer 2019. A case management conference has been scheduled for January 2019. Individual trial dates are not finalized yet; they will be released in a separate order.

More than 2,000 federal cases are pending with allegations that Bristol-Myers Squibb and Otsuka Pharmaceuticals marketed Abilify without warning consumers about the risks of compulsive gambling and unusual destructive behaviors. Abilify lawsuits are consolidated into multidistrict litigation before U.S. District Judge M. Casey Rodgers in the Northern District of Florida for coordinated discovery and pre-trial proceedings.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!